Grandeur Peak Global Advisors sold 709,697 shares of Bruker in Q3, decreasing position value by $29.54 million. As of September 30, they held 34,097 shares worth $1.11 million. Bruker’s stock price is at $47.85, down 18% in the past year. Revenue declined 0.5% in Q3, with organic revenue down 4.5%. EPS was $0.45, down from $0.60. Full-year guidance predicts up to a 5% organic revenue decline. Bruker focuses on advanced scientific instruments and analytical solutions for research and healthcare markets globally. Management aims for cost cuts and margin improvements in 2026 to address current challenges.

Read more at Nasdaq: Why a $30 Million Bruker Stock Trim Matters Amid an 18% Slide